9,233
Views
15
CrossRef citations to date
0
Altmetric
Review Article

Plants and plant products with potential antipsoriatic activity – a review

&
Pages 1573-1591 | Received 01 Jan 2012, Accepted 26 Apr 2012, Published online: 12 Sep 2012

References

  • Arnold WP, Glade CP, Mier PD, van de Kerkhof PC. (1993). Effects of sphingosine, isoquinoline and tannic acid on the human tape-stripping model and the psoriatic lesion. Skin Pharmacol, 6, 193–199.
  • Arora SK, Srivastava V, Walunj SS. (2009).Purified arabinogalactan-protein (AGP) composition useful in the treatment psoriasis and other disorders. US Pat Appl 20090264341, A1.
  • Babu UV, MishraB. (2011). Novel herbal composition for treatment of psoriasis and other skin disorders. US Pat Appl US 20110165136, A1.
  • Badmajew V. (1988). A Chinese medicinal composition for the treatment of stress and peripheral vascular disease. Eur Pat Appl EP 265662, A2.
  • Bai Y, WangY, Yang D, Zeng J, Liu D. (2007). Mechanism study of traditional Chinese patent medicine of quyin granule on treatment of psoriasis. China J Trad Chinese Med Pharm, 22, 184–186.
  • Bernstein JE, Parish LC, Rapaport M, Rosenbaum MM, Roenigk HH Jr. (1986). Effects of topically applied capsaicin on moderate and severe psoriasis vulgaris. J Am Acad Dermatol, 15, 504–507.
  • Bernstein S, Donsky H, Gulliver W, Hamilton D, Nobel S, Norman R. (2006). Treatment of mild to moderate psoriasis with Reliéva, a Mahonia aquifolium extract–a double-blind, placebo-controlled study. Am J Ther, 13, 121–126.
  • Bettuzzi S, Corvetta S. (2008). Preparation of catechin containing lotion for effective treatment of the scalp. Ital Pat IT 1345090, 11pp.
  • Briffa DV, Warin AP. (1979). Photochemotherapy in psoriasis: A review. J R Soc Med, 72, 440–446.
  • Bito T, Roy S, Sen CK, Packer L. (2000). Pine bark extract pycnogenol downregulates IFN-gamma-induced adhesion of T cells to human keratinocytes by inhibiting inducible ICAM-1 expression. Free Radic Biol Med, 28, 219–227.
  • Butler D. (2005). Extracts of Mimulus aurantiacus for treating psoriasis and repelling insects. US Pat Appl 20050152996, A1.
  • Champion RH. (1981). Psoriasis and its treatment. Br Med J (Clin Res Ed), 282, 343–346.
  • Chen C, Zhang G. (1987). An ultrastructural study on changes of psoriatic skin after photo-herbal therapy of Anglica dahurica and ultraviolet A. Acta Acad Med Militaris Tertiae, 3, 113–114.
  • Chen M, Wang A, YaoY. (2001). Treatment of psoriasis by yinkang granules: a clinical observation of 98 cases. New J Trad Chinese Med, 33, 19–23.
  • Cheng J, Cheng G. (2011). Nano element/ Chinese herb textile antibacterial underwear for prevention and treatment of psoriasis. Faming Zhuanli Shenqing CN 102078029, A, 7pp.
  • Cimmino MA. (2007). Epidemiology of psoriasis and psoriatic arthritis. Reumatismo, 59 Suppl 1, 19–24.
  • Claes C, Kulp W, Greiner W, Von der Schulenburg JM, Werfel T.. (2006). Therapy of moderate and severe psoriasis. GMS Health Technol [Online]. Available at: www.ncbi.nlm.nih.gov/pmc/articles/PMC3011355/. Accessed on 02 Dec 2007.
  • Cohen AD, Shalev R, Yaniv R, Shemer A. (2007). An open-label study of an herbal topical medication (QoolSkin) for patients with chronic plaque psoriasis. Sci World J, 7, 1063–1069.
  • Cui BN, Sun YX, Liu WL. (2008). Clinical efficacy of narrow band ultraviolet bin combined with yuyin recipe in treating psoriasis vulgaris]. Zhongguo Zhong Xi Yi Jie He Za Zhi, 28, 355–357.
  • Dang X. (2008). Chinese herbal medicine for external use for treating psoriasis, neurodermatitis, tinea corporis, tinea cruris, pityriasis versicolor, tinea hand or pedis. Faming Zhuanli Shenqing CN 101229336, A, 8pp.
  • Dantow JE. (1992). Treatment options in psoriasis: Tailoring treatment to the patient’s needs. Can Fam Physician, 38, 857–860.
  • Dave AR, Shukla VD. (2006). Role of Amrutbhallatak Avaleha & Karanjadi Lepa in the management of Ekakushtha (Psoriasis). AYU, 27, 16–21.
  • Dodou K, Anderson RJ, Lough WJ, Small DAP, Shelley MD, Groundwater PW. (2005). Synthesis of gossypol atropisomers and derivatives and evaluation of their anti-proliferative and anti-oxidant activity. Bioorg Med Chem, 13, 4228–4237.
  • Ellis CN, Berberian B, Sulica VI, Dodd WA, Jarratt MT, Katz HI, Prawer S, Krueger G, Rex IH Jr, Wolf JE. (1993). A double-blind evaluation of topical capsaicin in pruritic psoriasis. J Am Acad Dermatol, 29, 438–442.
  • Epstein JD. (1987). Current treatment of psoriasis. Can Fam Physician, 33, 2349–2354.
  • Farber EM, McClintock RP Jr. (1968). A current review of psoriasis. Calif Med, 108, 440–457.
  • Feng J, Xu HQ, Su BS. (1996). Influence of qingdai compound capsule (QDCC) on the expression of c-myc in psoriatic keratinocytes. Zhongguo Zhong Xi Yi Jie He Za Zhi, 16, 146–148.
  • Ferrando J. (1986). Clinical trial of a topical preparation containing urea, sunflower oil, evening primrose oil, wheat germ oil and sodium pyruvate, in several hyperkeratotic skin conditions. Med Cutan Ibero Lat Am, 14, 133–137.
  • Fu G. (2000). A Chinese medicinal composition for treating tinea such as psoriasis, and preparation method thereof. Faming Zhuanli Shenqing CN 1256949. A.
  • Fulder S, Said O, Khalil K, Cohen E. (2010). Pharmaceutical compositions comprising herb extracts for treating psoriasis. Israeli Pat IL 138473, A, 41 pp.
  • Gabriel Z, Martin L. (2009). Use of mimosine or a derivative thereof for treating the cutaneous effects of psoriasis and related skin disorders, and cosmetic or pharmaceutical composition containing same. US Pat Appl 20090220622, A1.
  • Gao BA, Xu X. (2001). Assessment on effect of treatment of chronic plaque type psoriasis by combination therapy of composite shendi decoction and diyin tablet. Zhongguo Zhong Xi Yi Jie He Za Zhi, 21, 15–18.
  • Gao X. (2010). External use traditional Chinese medicinal composition for treating psoriasis. Faming Zhuanli Shenqing CN 101732425, A, 7pp.
  • Gao Y. (2005). A medicinal composition for the treatment of dermatoses including psoriasis. Faming Zhuanli Shenqing CN 1613501, A.
  • García-Pérez ME, Royer M, Duque-Fernandez A, Diouf PN, Stevanovic T, Pouliot R. (2010). Antioxidant, toxicological and antiproliferative properties of Canadian polyphenolic extracts on normal and psoriatic keratinocytes. J Ethnopharmacol, 132, 251–258.
  • Garneau R. (2008). Therapeutic herbal tea. Can Pat Appl CA 2559230, A1, 8 pp..
  • Ghosh A, Mandal S, Banerji A, Kar M, Hazra K, Banerji J. (2011). A novel biflavonyloxymethane from Pongamia pinnata and its radical quenching activity. Nat Prod Commun, 6, 625–626.
  • Gieler U, von der Weth A, Heger M. (1995).Mahonia aquifolium: A new type of topical treatment for psoriasis. J Dermatolog Treat, 6, 31–34.
  • Gomez HJ. (2006). Pharmaceutical compositions for the treatment of psoriasis. US Pat Appl 20060286054, A1.
  • Gu MJ, Gao SP, Li YM. (2009). Effects of Liangxue Jiedu Decoction in treating psoriasis in a mouse psoriasis model. Zhong Xi Yi Jie He Xue Bao, 7, 552–556.
  • Gulliver WP, Donsky HJ. (2005). A report on three recent clinical trials using Mahonia aquifolium 10% topical cream and a review of the worldwide clinical experience with Mahonia aquifolium for the treatment of plaque psoriasis. Am J Ther, 12, 398–406.
  • Harries MJ, Chalmers RJ, Griffiths CE. (2005). Fumaric acid esters for severe psoriasis: A retrospective review of 58 cases. Br J Dermatol, 153, 549–551.
  • Hasse C. (2000). A medicinal ointment containing extracts of Arnica herb, marigold and Fructus Rhodomyrti used for treating psoriasis, skin dryness, chapped skin, pruritis, abrasion and scald. Ger Gebrauchsmusterschrift DE 20001736, U1.
  • Horvath F. (1993). Therapeutical compositions against psoriasis . Eur Pat Appl EP0364442, B1
  • Huang S, Huang X. (2005). A Chinese herbal tea for treating dermatoses and its preparation method. Faming Zhuanli Shenqing, CN 1711864, A.
  • Huang T, Lin X. (1996).Effects of camptothecin on proliferation and differentiation of keratinizing epithelium. The Chin J Dermatovenereol, 10, 325–327.
  • Ito K, Namikawa S, Takeuchi K. (1992). Effect of the dry distillation tar of delipidated soybean (Glyteer) on a psoriasic model in the mouse. Nihon Yakurigaku Zasshi, 99, 55–62.
  • Jin HL, Zhang RZ, Gao YX. (2007).Effect of artesunate on keratinocyte cultured in vitro. Chin J Trad Med Sci Tech, 14, 176–178.
  • Kamuhabwa AR, Roelandts R, de Witte PA. (1999). Skin photosensitization with topical hypericin in hairless mice. J Photochem Photobiol B, 53, 110–114.
  • Kanaujia P, Balakrishnan R, Rajan J, Katageri SB. (2010). Stable hydrophobic topical herbal formulation. US Pat Appl 20100255131, A1.
  • Kapaj TS. (2005). Pharmaceutical ointment for the complete therapy of dermatologic diseases. Eur Pat Appl EP1532982, A2.
  • Khan MS, Siddiqui MMH, Aleem S. (2009). Effect of Psoralia corylifolia Linn. and Marham-e-Gulabi in Da-al-sadaf (psoriasis). Indian J Trad Knowledge, 8, 425–430
  • Krueger J, Bowcock A. (2005). Psoriasis pathophysiology: Current concepts of pathogenesis. Ann Rheum Dis, 64(Suppl II), ii30–ii36.
  • Kalyan Kumar G, Dhamotharan R, Kulkarni NM, Mahat MY, Gunasekaran J, Ashfaque M. (2011). Embelin reduces cutaneous TNF-a level and ameliorates skin edema in acute and chronic model of skin inflammation in mice. Eur J Pharmacol, 662, 63–69.
  • Kurd SK, Smith N, VanVoorhees A, Troxel AB, Badmaev V, Seykora JT, Gelfand JM. (2008). Oral curcumin in the treatment of moderate to severe psoriasis vulgaris: A prospective clinical trial. J Am Acad Dermatol, 58, 625–631.
  • Lange T, Juergen GN. (2003). Combination treatment of wounds, psoriasis and neurodermatitis using herbal extracts in form of infusion drinks and ointments. Ger Offen DE 10213480, A1, 4pp.
  • Langley RGB, Krueger GG, Griffiths CEM. (2005). Psoriasis: Epidemiology, clinical features, and quality of life. Ann Rheum Dis, 64 (Suppl II), ii18–ii23.
  • Lassus A, Rosen B. (1986). Response of solitary psoriatic plaques to experimental application of podophyllotoxin. Dermatologica, 172, 319–322.
  • Ledón N, Casacó A, Remirez D, González A, Cruz J, González R, Capote A, Tolón Z, Rojas E, Rodríguez VJ, Merino N, Rodríguez S, Ancheta O, Cano MC. (2007). Effects of a mixture of fatty acids from sugar cane (Saccharum officinarum L.) wax oil in two models of inflammation: zymosan-induced arthritis and mice tail test of psoriasis. Phytomedicine, 14, 690–695.
  • Li FL, Li B, Xu R, Song X, Yu Y, Xu ZC. (2008). Qinzhu Liangxue Decoction in treatment of blood-heat type psoriasis vulgaris: a randomized controlled trial. Zhong Xi Yi Jie He Xue Bao, 6, 586–590.
  • Lin J, Liu X, Bao Y, Hou S, An L, Lin X. (2008a). Effects of isocamptothecin, a novel camptothecin analogue, on proliferation, apoptosis and telomerase activity in HaCaT cells. Exp Dermatol, 17, 530–536.
  • Lin YK, Chang CJ, Chang YC, Wong WR, Chang SC, Pang JH. (2008b). Clinical assessment of patients with recalcitrant psoriasis in a randomized, observer-blind, vehicle-controlled trial using indigo naturalis. Arch Dermatol, 144, 1457–1464.
  • Lin YK, Leu YL, Yang SH, Chen HW, Wang CT, Pang JH. (2009). Anti-psoriatic effects of indigo naturalis on the proliferation and differentiation of keratinocytes with indirubin as the active component. J Dermatol Sci, 54, 168–174.
  • Liu B, Li Y, Han L. (1999).Study on anti-immune and anti-inflammatory actions of Yinxue Ling. Liaoning J Trad Chinese Med, 26, 37–42.
  • Liu H, Ouyang H, Yang Z. (2005a).The effects of Xian-fang-xiao-yin tablet on the plasma endothelin-1 and calcitonin gene related peptide of psoriasis. Chin J Lepr Skin Dis, 12, 13–15.
  • Liu HJ, Shi XM, Ou YH, Yang ZB, Lu GQ. (2006).Study on the efficacy of Xianfangxiaoyinpian on the granular cell proliferation in flake of the mouse tail. Southern China J Dermato-Venereol, 13, 80–81.
  • Liu HQ, Lei MJ, Wanc GH. (2005b).Treatment of Psoriasis vulgaris by Yinxiebing external bath formula and narrow-spectrum midwave ultraviolet irradiation: a clinical observation of 40 cases. New J Trad Chinese Med, 37, 117–119.
  • Liu ZY, Wang JS, Wang P, Li P, Wang LH. (2010).Clinical observation of Liangxue Jiedu decoction for white facial skin disease (Psoriasis vulgaris) of blood heat syndrome. World J Integr Trad West Med, 5, 17–21.
  • Lone AH, Ahmad T, Naiyar AH. (2011). Clinical evaluation of efficacy of Majoon Ushba and Roghane Hindi in the management of psoriasis: A randomized single-blind, placebo-controlled study. J Ayurveda Integr Med, 2, 26–31.
  • Man MQ, Shi Y, Man M, Lee SH, Demerjian M, Chang S, Feingold KR, Elias PM. (2008). Chinese herbal medicine (Tuhuai extract) exhibits topical anti-proliferative and anti-inflammatory activity in murine disease models. Exp Dermatol, 17, 681–687.
  • Mao SH, Qin JZ, Li YK. (1997). Clinical studies on liangxue piyan granule no. 2 in treating psoriasis. Zhongguo Zhong Xi Yi Jie He Za Zhi, 17, 219–220.
  • Meisner LF. (2005). Topical composition for the treatment of psoriasis and related skin disorders. US Pat Appl 20050003023, A1.
  • Mi C, Shi H, Li F. (2006). Method for isolating abietic acid and traditional Chinese herbs for treating psoriasis. Faming Zhuanli Shenqing CN 1883519, A, 7pp.
  • Mo G. (2001). A Chinese medicinal composition for the treatment of psoriasis, and its preparation method. Faming Zhuanli Shenqing CN 1318404, A.
  • Mrowietz U, Reich K. (2009). Psoriasis–new insights into pathogenesis and treatment. Dtsch Arztebl Int, 106, 11–19.
  • Muruganantham N, Basavaraj KH, Dhanabal SP, Praveen TK, Shamasundar NM, Rao KS. (2011). Screening of Caesalpinia bonduc leaves for antipsoriatic activity. J Ethnopharmacol, 133, 897–901.
  • Naldi L, RzanyB. (2009).Psoriasis (chronic plaque). Clin Evid [Online]. Available at: http://www.ncbi.nlm.nih.gov/pubmed/19445765. Accessed on 17 Feb 2011.
  • Ohta T, Yamaguchi M, Tokuda H. (2010). Proliferation effect of Tahuba NFD on human keratinocytes. Pacifichem – The International Chemical Congress of Pacific Basin Societies, 15–20 Dec, 2010, Honolulu, Hawaii.
  • Pasini I. (1991). Phytopreparation for treating skin affections. Eur Pat Appl EP0297640, B1.
  • Perez C. (1993). Pharmaceutical compositions containing plant extracts and mercury derivatives for treatment of psoriasis. Fr Demande FR 2690344, A1, 14pp.
  • Phan D. (2003). Methods of treatment for skin disorders using turmeric extract and a hydroxy acid. > US Pat Appl 20030113388, A1.
  • Pushpangandan P, Rajasekharan S, George V, Singh OV. (2009). A process of manufacture of antipsoriatic and antidandruff drug from plant extracts. Indian Pat Appl IN 1999MA00257, A, 9pp.
  • Qiang JF, Cao SL, Chen W. (2008). Observation of Chinese medicine ginkgo and megranate treatment and its affection on VEGF and PIGF in patients with psoriasis. The Chin J Dermatovenereol, 22, 496–497.
  • Qiu S, Tan S, Zhang J, Liu P, Ran L, Lei X. (2005). Effect of liangxue huoxue xiaoyin tang on serum levels of TNF-alpha, IFN-gamma and IL-6 in psoriasis of blood-heat type. J Tradit Chin Med, 25, 292–295.
  • Reddy NBB, Kumar S, Reddy VN, Torgalkar A, Murugan NR. (2008). Compositions for the regression of dermal vessel tortuosity. US Pat Appl Publ US 20080160113, A1, 9pp.
  • Sampson JH, Raman A, Karlsen G, Navsaria H, Leigh IM. (2001). In vitro keratinocyte antiproliferant effect of Centella asiatica extract and triterpenoid saponins. Phytomedicine, 8, 230–235.
  • Sanchez JLA. (2009). Herbal composition for the treatment of psoriasis. Mex Pat Appl MX 2007010360, A.
  • Saple DG, Medhekar S, Patil M. (2008). Imupsora – a herbal formulation for the management of psoriasis (a clinical study). In: Phytopharmacology and Therapeutic Values III, 525–533.
  • Seo WS, Kang BC, Kim GN, Kim JH. (2009). Medicinal herb extracts for the treatment of psoriasis. Repub Korean Kongkae Taeho Kongbo KR 2009063989, A, 11pp.
  • Shin YW, Bae EA, Kim SS, Lee YC, Kim DH. (2005). Effect of ginsenoside Rb1 and compound K in chronic oxazolone-induced mouse dermatitis. Int Immunopharmacol, 5, 1183–1191.
  • Shiri J, Cohen A. (2010). An open-label study of an herbal topical medication (Psirelax) for patients with chronic plaque psoriasis. 33rd Annual meeting of Israel Society of Dermatology and Venereology, 16–17 June, 2010, Meridian Hotel, Dead Sea, Israel.
  • Shrivastav S, Sindhu RK, Kumar S, Kumar P. (2009). Anti-psoriatic and phytochemical evaluation of Thespesia populnea bark extracts. Int J Pharm Pharm Sci, 1, 176–185.
  • Smith CH, Barker JN. (2006). Psoriasis and its management. BMJ, 333, 380–384.
  • Song R, Yuan J, Wang Y. (2002). Study on therapeutic effect of compound radix sophorae flavescentis injection. Chin J Modern Appl Pharm, 19, 177–179.
  • Stücker M, Memmel U, Hoffmann M, Hartung J, Altmeyer P. (2001). Vitamin B(12) cream containing avocado oil in the therapy of plaque psoriasis. Dermatology (Basel), 203, 141–147.
  • Sun J, Xu C. (2009).Effect of Jiedu Quyu formula for Psoriasis vulgaris and its influence on plasma endothelin. J Tradit Chin Med, 29, 347–349.
  • Sun J, Zhang HY, Liu XP. (2010).Effects of compound Zeqi granules on life quality in patients with Psoriasis vulgaris in active stage. J Anhui Trad Chinese Med College, 29, 30–32.
  • Susilo R. (2010). Pandanus conoideus plant extracts for treating skin diseases. PCT Int Appl WO 2010108488, A2, 54 pp.
  • Syed TA, Ahmad SA, Holt AH, Ahmad SA, Ahmad SH, Afzal M. (1996). Management of psoriasis with Aloe vera extract in a hydrophilic cream: A placebo-controlled, double-blind study. Trop Med Int Health, 1, 505–509.
  • Tang JH. (2004). Psoriasis treatment. US Pat Appl 20040071791, A1.
  • Thanikkal JV. (2008). Novel herbal compositions for skin disorders and process of preparation thereof. Indian Pat Appl IN 2006CH01387, A.
  • Traub M, Marshall K. (2007). Psoriasis–pathophysiology, conventional, and alternative approaches to treatment. Altern Med Rev, 12, 319–330.
  • Tse WP, Che CT, Liu K, Lin ZX. (2006). Evaluation of the anti-proliferative properties of selected psoriasis-treating Chinese medicines on cultured HaCaT cells. J Ethnopharmacol, 108, 133–141.
  • Vasänge M, Rolfsen W, Bohlin L. (1997). A sulphonoglycolipid from the fern Polypodium decumanum and its effect on the platelet activating-factor receptor in human neutrophils. J Pharm Pharmacol, 49, 562–566.
  • Wahba A, Cohen H. (1980). Therapeutic trials with oral colchicine in psoriasis. Acta Derm Venereol, 60, 515–520.
  • Wang L, Huang Y, Wang M. (2009).Clinical observation of Yinxieling tablets for the treatment of Psoriasis vulgaris. J Guangzhou Univ Trad Chinese Med, 26, 520–522.
  • Wang L, Wang L. (2004). An external used traditional Chinese medicinal liquid for the treatment of psoriasis. Faming Zhuanli Shenqing CN 1475236, A.
  • Wang Y, Shi J, Dong X, Chen Q, Yang J. (2003).Clinical and hemorrheological observation of psoriasis treated with Zicaohuoxue decoction. J Xi’an Med Univ (Chinese), 24, 275–277.
  • Wee SS, Shin YW, Bae EA, Kim DH. (2005). Effect of chunghyuldan in chronic oxazolone-induced mouse dermatitis. Biol Pharm Bull, 28, 1079–1082.
  • Wei G, Yue CW, Zhang CM. (2008). Effect of fumigation therapy with yinxieling on T-bet and GATA-3 protein expression in the peripheral blood monocyte of patients with psoriasis vulgaris. Zhongguo Zhong Xi Yi Jie He Za Zhi, 28, 1118–1120.
  • Wendorff D. (1992). Composition containing Herba Chelidonii for topical treatment of psoriasis and preparation method thereof. Ger Offen DE 4031960, A1.
  • Wilkinson JD, Williamson EM. (2007). Cannabinoids inhibit human keratinocyte proliferation through a non-CB1/CB2 mechanism and have a potential therapeutic value in the treatment of psoriasis. J Dermatol Sci, 45, 87–92.
  • Wuttke W. (2009). Cosmetic or dermatological composition for topical application containing Cimicifuga extract Ger Offen DE 102007044916, A1, 7pp..
  • Xi J, Chen O, Tian Y. (2008). Effect of Yinxie capsules for Psoriasis vulgaris: An observation of 40 cases. J New Chinese Med, 40, 760–763.
  • Yang DQ, Jiang YF, Zhang Y. (2005). Observation on effect of pifubing xuedu pill combined with diyin tablet in treatment of psoriasis. Zhongguo Zhong Xi Yi Jie He Za Zhi, 25, 740–742.
  • Yang LP, Jiang XF, Guang YB. (1996). Clinical observation on fumigation and inhalation of huayin powder in treating psoriasis. Zhongguo Zhong Xi Yi Jie He Za Zhi, 16, 655–657.
  • Yang Z, Ouyang H, Luo WH. (2001). Clinical study on effect of zhuhuang granule no. 2 in treating psoriasis with liver-qi stagnancy. Zhongguo Zhong Xi Yi Jie He Za Zhi, 21, 269–271.
  • Yehuda H, Khatib S, Sussan I, Musa R, Vaya J, Tamir S. (2009). Potential skin antiinflammatory effects of 4-methylthiobutylisothiocyanate (MTBI) isolated from rocket (Eruca sativa) seeds. Biofactors, 35, 295–305.
  • Yuqi TT. (2005). Review of a treatment for psoriasis using herose, a botanical formula. J Dermatol, 32, 940–945.
  • Zachariae H, Kragballe K, Herlin T. (1982). Colchicine in generalized pustular psoriasis: Clinical response and antibody-dependent cytotoxicity by monocytes and neutrophils. Arch Dermatol Res, 274, 327–333.
  • Zhang H, Xu XG, Gu J. (2008). Effect of xiaoyin recipe in treatment of psoriasis patients of blood-heat syndrome type and its impact on peripheral Th1/Th2 equilibrium. Zhongguo Zhong Xi Yi Jie He Za Zhi, 28, 683–685.
  • Zhang LL, Huang CQ, Zhang ZY, Wang ZR, Lin JM. (2005). Therapeutic effects of koumine on psoriasis: an experimental study in mice. Di Yi Jun Yi Da Xue Xue Bao, 25, 547–549.
  • Zhou DY, Zhou LL, Liu L, Pun ECH, Lin ZX. (2011).Investigation of the anti-proliferative effect and the underlying mechanism of the crude extract of Celastrus orbiculatus on human HaCaT keratinocytes. Univ Toronto J Undergrad Life Sci, 5, 1–5.
  • Zhou M, Tao LC. (2005). Therapeutic efficacy of lixue xiaoyin decoction in treating psoriasis and its effect on plasma edothelin. Zhongguo Zhong Xi Yi Jie He Za Zhi, 25, 929–931.
  • Zhou N, Bai YP, Man XH, Zhang YB, Kong YH, Ju H, Chang M. (2009). Effect of new Pulian Ointment in treating psoriasis of blood-heat syndrome: A randomized controlled trial. Chin J Integr Med, 15, 409–414.
  • Zhou S, Wang S. (2008). Traditional Chinese medicine for external use for treating psoriasis..

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.